How to navigate China’s regulatory environment

Published on: Feb 15, 2023

Hear Parexel’s China Regulatory experts share their assessment of the current landscape, registration and regulatory pathways, and offer practical advice on CDE meetings and HDA communication.

Return to Insights Center

Related Insights

Audiogram

Fast-track to UK market: Mastering the MHRA's recognition procedure

Sep 3, 2025

Whitepaper

Advancing clinical development through innovative trial design

Nov 3, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Article

The technologies that are reshaping biotherapeutics manufacturing, an EU perspective

Jul 6, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Related Insights

Audiogram

Fast-track to UK market: Mastering the MHRA's recognition procedure

Sep 3, 2025

Whitepaper

Advancing clinical development through innovative trial design

Nov 3, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Show more